Bevacizumab (Bev)-based therapy for patients (pts) with colorectal cancer (CRC): McGill University and Segal Cancer Centre experience

Journal article

Peer reviewed

D. W. Wasserman, N. Bouganim, G. Batist, P. Metrakos, P. Chaudhury, M. Hassanain and P. Kavan

Journal of clinical oncology, Vol.29(15_suppl), pp.e14158-e14158

20/05/2011

Abstract

Abstract only

1 Record Views

Title: Bevacizumab (Bev)-based therapy for patients (pts) with colorectal cancer (CRC): McGill University and Segal Cancer Centre experience
Creators - without role: D. W. Wasserman
N. Bouganim
G. Batist
P. Metrakos
P. Chaudhury
M. Hassanain
P. Kavan
Publication Details: Journal of clinical oncology, Vol.29(15_suppl), pp.e14158-e14158
Identifiers: 9952884608331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article